This study investigates pancreatic cancer with a focus on patients who have undergone surgery and chemotherapy. The purpose of this study is to explore the effects of an investigational medication following these treatments in patients with specific genetic mutations.
The study evaluates the safety and effectiveness of the investigational medication. It examines how well the medication works in maintaining health after surgery and chemotherapy in patients with pancreatic cancer.
- Who can participate: Adults aged 18 and older with pancreatic cancer, who have had surgery and chemotherapy, may be eligible if they have a specific genetic mutation.
- Study details: Participants will take an investigational medication or a placebo, which looks like the investigational medication but contains no active ingredients. They will have regular check-ups and tests during the study.
How understandable was the trial content above?
Hard to understand
Easy to understand